https://www.selleckchem.com/products/ana-12.html
Background Split thickness skin grafting (SSG) is an important modality for wound coverage; however, it leads to donor site morbidity. Epidermal grafting (EG) is a promising option for autologous skin grafting which offers minimal donor site morbidity, though it is not known if EG is an effective clinical alternative for SSG. This study compared the efficacy of EG as an alternative to SSG in terms of wound healing outcomes, donor site morbidity, patient satisfaction and adverse events. Methods EPIGRAAFT is a Phase 2, randomized, open-lab
Curtir
Comentario
Compartilhar
